Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tse Hui Lim

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Oncotarget|March 20, 2016
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerChye Ling Tan, Tse Hui Lim, Tony Kh Lim, et al.
Annals of the Academy of Medicine, Singapore|October 20, 2010
Bone marrow cytogenetics workup: Application of lean management system to determine if additional cell workup is helpful and necessary to analysisAlvin S T Lim, Ting Jie Chen, Tse Hui Lim, et al.
Chinese Medical Journal|May 16, 2013
Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in SingaporeAlvin Soon Tiong Lim, Tse Hui Lim, Karen Hsu Shien See, et al.
Histopathology|June 28, 2026
Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challengesSompon Apornvirat, Edward Jaya Hadi, Mihir Gudi, et al.
Science Advances|June 16, 2023
Cord blood-derived V<sub>δ</sub>2<sup>+</sup> and V<sub>δ</sub>2<sup>-</sup> T cells acquire differential cell state compositions upon in vitro expansionJeremy Wee Kiat Ng, Kar Wai Tan, Dian Yan Guo, et al.
JCO Global Oncology|April 22, 2020
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated CholangiocarcinomaSarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Oncotarget|March 20, 2016
Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancerChye Ling Tan, Tse Hui Lim, Tony Kh Lim, et al.
Annals of the Academy of Medicine, Singapore|October 20, 2010
Bone marrow cytogenetics workup: Application of lean management system to determine if additional cell workup is helpful and necessary to analysisAlvin S T Lim, Ting Jie Chen, Tse Hui Lim, et al.
Chinese Medical Journal|May 16, 2013
Cytogenetic and molecular aberrations of multiple myeloma patients: a single-center study in SingaporeAlvin Soon Tiong Lim, Tse Hui Lim, Karen Hsu Shien See, et al.
Histopathology|June 28, 2026
Malignant adenomyoepithelioma of the breast: seven cases illustrating morphological diversity and diagnostic challengesSompon Apornvirat, Edward Jaya Hadi, Mihir Gudi, et al.
Science Advances|June 16, 2023
Cord blood-derived V<sub>δ</sub>2<sup>+</sup> and V<sub>δ</sub>2<sup>-</sup> T cells acquire differential cell state compositions upon in vitro expansionJeremy Wee Kiat Ng, Kar Wai Tan, Dian Yan Guo, et al.
JCO Global Oncology|April 22, 2020
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated CholangiocarcinomaSarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, et al.
Nature Medicine|October 3, 2017
Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrenceJian Yuan Goh, Min Feng, Wenyu Wang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2020
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLCAaron C Tan, Amanda O L Seet, Gillianne G Y Lai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
JCO Precision Oncology|July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center ExperienceAmanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Pageof 4